Fact CheckerSign in

NCT06101862Recruiting

Coronary Computed Tomography Versus Invasive Angiography for Non-ST Elevation Acute Coronary Syndrome

Team-based Interventional Triage in Acute Coronary Syndrome Based on Non-Invasive Computed Tomography Coronary Angiography - a Randomized Trial

Source: ClinicalTrials.gov · Last updated 19 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Coronary computed tomography angiography (CCTA) is a widely accepted initial diagnostic test for individuals suspected of having chronic coronary syndromes. However, there is limited evidence supporting its use in the acute setting. So far, no large-scale randomized trial has examined the performance of CCTA as an alternative to invasive coronary angiography (ICA) in individuals with non-ST-segment elevation myocardial infarction (NSTEACS). If CCTA were to replace ICA as a routine procedure for individuals with NSTEACS, it could reduce the risk of complications related to ICA, improve patient comfort, expedite decision-making, and reduce healthcare expenses and interhospital transfers.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
2300 (estimated)
First submitted
28 Sept 2023
Start date
1 Oct 2023
Primary completion date
1 Oct 2026
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
NCT number
NCT06101862

What you commit to

  • Study type: Interventional
  • Planned participants: 2300
  • From 1 Oct 2023 to the primary completion date, 1 Oct 2026
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior CCTA or ICA during index admission or within 1 week
  • Previously randomized in this trial

Other illness

  • History of percutaneous coronary intervention or coronary artery bypass grafting
  • Probable type 2 acute myocardial infarction
  • Severe valvular heart disease as primary diagnosis or potential need for valve intervention
  • History of spontaneous coronary artery dissection
  • Known allergy to beta-blockers or contrast agent

Other

  • Instability requiring acute or emergent ICA
  • Estimated glomerular filtration rate \< 30 mL/min/1.73m2
  • Expected poor quality of the CCTA
  • Pregnant or nursing

Who the study is looking for

  • Admitted with non-ST-segment elevation myocardial infarction or unstable angina pectoris and an indication for subacute ICA
  • Elevated troponin or ischemic electrocardiographic changes
  • Written informed consent

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Bispebjerg Hospital
Coordinator of this site? Confirm its status
BispebjergDenmarkRecruiting
Herlev and Gentofte Hospital
Coordinator of this site? Confirm its status
CopenhagenDenmarkRecruiting
Zealand University Hospital
Coordinator of this site? Confirm its status
CopenhagenDenmarkRecruiting
Rigshospitalet
Coordinator of this site? Confirm its status
CopenhagenDenmarkRecruiting
North Zealand Hospital
Coordinator of this site? Confirm its status
HillerødDenmarkRecruiting
Hvidovre Hospital
Coordinator of this site? Confirm its status
HvidovreDenmarkRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.